Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Buy
90
MNDR Quote, Financials, Valuation and Earnings
Last price:
$0.39
Seasonality move
:
--
Day range:
$0.34 - $0.39
52-week range:
$0.23 - $29.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.93x
P/B ratio:
3.15x
Volume:
735.2K
Avg. volume:
560.5K
1-year change:
--
Market cap:
$13M
Revenue:
$14M
EPS (TTM):
-$0.45
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
-- | -- | -- | -- | -- |
|
EUDA
EUDA Health Holdings
|
$2.6M | -$0.02 | 1702.91% | -92.93% | -- |
|
GDTC
CytoMed Therapeutics
|
$130K | -$0.04 | -- | -- | -- |
|
HAWPF
Haw Par
|
-- | -- | -- | -- | -- |
|
RAFLF
Raffles Medical Group
|
-- | -- | -- | -- | -- |
|
WVE
WAVE Life Sciences
|
$25.6M | -$0.24 | -11.91% | -61.85% | $22.30 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
$0.38 | -- | $13M | -- | $0.00 | 0% | 0.93x |
|
EUDA
EUDA Health Holdings
|
$4.50 | -- | $167.2M | -- | $0.00 | 0% | 64.70x |
|
GDTC
CytoMed Therapeutics
|
$3.45 | -- | $39.8M | -- | $0.00 | 0% | -- |
|
HAWPF
Haw Par
|
$8.00 | -- | $1.8B | 10.66x | $0.15 | 3.76% | 10.01x |
|
RAFLF
Raffles Medical Group
|
$0.67 | -- | $1.2B | 27.83x | $0.02 | 2.66% | 2.41x |
|
WVE
WAVE Life Sciences
|
$13.51 | $22.30 | $2.1B | -- | $0.00 | 0% | 31.64x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
-- | 0.000 | -- | 2.20x |
|
EUDA
EUDA Health Holdings
|
-69.68% | 1.197 | 2.25% | 0.07x |
|
GDTC
CytoMed Therapeutics
|
-- | -4.457 | -- | -- |
|
HAWPF
Haw Par
|
0.97% | 0.174 | 1.68% | 27.90x |
|
RAFLF
Raffles Medical Group
|
6.41% | 0.046 | 3.7% | 1.17x |
|
WVE
WAVE Life Sciences
|
-- | 1.456 | -- | 1.82x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
-- | -- | -1223.46% | -1223.46% | -- | -- |
|
EUDA
EUDA Health Holdings
|
-- | -- | -- | -- | -- | -- |
|
GDTC
CytoMed Therapeutics
|
-- | -- | -- | -- | -- | -- |
|
HAWPF
Haw Par
|
-- | -- | 6.56% | 6.62% | -- | -- |
|
RAFLF
Raffles Medical Group
|
-- | -- | 5.51% | 5.89% | -- | -- |
|
WVE
WAVE Life Sciences
|
-- | -$63.9M | -437.99% | -437.99% | 832.66% | -$46.9M |
Mobile-health Network Solutions vs. Competitors
-
Which has Higher Returns MNDR or EUDA?
EUDA Health Holdings has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat EUDA Health Holdings's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M EUDAEUDA Health Holdings-- -- -$3.5M -
What do Analysts Say About MNDR or EUDA?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 2018.64%. On the other hand EUDA Health Holdings has an analysts' consensus of -- which suggests that it could grow by 33.33%. Given that Mobile-health Network Solutions has higher upside potential than EUDA Health Holdings, analysts believe Mobile-health Network Solutions is more attractive than EUDA Health Holdings.
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 EUDAEUDA Health Holdings0 0 0 -
Is MNDR or EUDA More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison EUDA Health Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNDR or EUDA?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. EUDA Health Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. EUDA Health Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or EUDA?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than EUDA Health Holdings quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than EUDA Health Holdings's net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while EUDA Health Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.93x versus 64.70x for EUDA Health Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.93x -- -- -- EUDAEUDA Health Holdings64.70x -- -- --
-
Which has Higher Returns MNDR or GDTC?
CytoMed Therapeutics has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat CytoMed Therapeutics's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M GDTCCytoMed Therapeutics-- -- -- -
What do Analysts Say About MNDR or GDTC?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 2018.64%. On the other hand CytoMed Therapeutics has an analysts' consensus of -- which suggests that it could grow by 44.93%. Given that Mobile-health Network Solutions has higher upside potential than CytoMed Therapeutics, analysts believe Mobile-health Network Solutions is more attractive than CytoMed Therapeutics.
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 GDTCCytoMed Therapeutics0 0 0 -
Is MNDR or GDTC More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CytoMed Therapeutics has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNDR or GDTC?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoMed Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. CytoMed Therapeutics pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or GDTC?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than CytoMed Therapeutics quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than CytoMed Therapeutics's net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while CytoMed Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.93x versus -- for CytoMed Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.93x -- -- -- GDTCCytoMed Therapeutics-- -- -- --
-
Which has Higher Returns MNDR or HAWPF?
Haw Par has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat Haw Par's return on equity of 6.62%.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M HAWPFHaw Par-- -- $2.8B -
What do Analysts Say About MNDR or HAWPF?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 2018.64%. On the other hand Haw Par has an analysts' consensus of -- which suggests that it could fall by --. Given that Mobile-health Network Solutions has higher upside potential than Haw Par, analysts believe Mobile-health Network Solutions is more attractive than Haw Par.
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 HAWPFHaw Par0 0 0 -
Is MNDR or HAWPF More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Haw Par has a beta of 0.120, suggesting its less volatile than the S&P 500 by 88.041%.
-
Which is a Better Dividend Stock MNDR or HAWPF?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Haw Par offers a yield of 3.76% to investors and pays a quarterly dividend of $0.15 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. Haw Par pays out 35.78% of its earnings as a dividend. Haw Par's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MNDR or HAWPF?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than Haw Par quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than Haw Par's net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while Haw Par's PE ratio is 10.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.93x versus 10.01x for Haw Par. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.93x -- -- -- HAWPFHaw Par10.01x 10.66x -- --
-
Which has Higher Returns MNDR or RAFLF?
Raffles Medical Group has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat Raffles Medical Group's return on equity of 5.89%.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M RAFLFRaffles Medical Group-- -- $811.2M -
What do Analysts Say About MNDR or RAFLF?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 2018.64%. On the other hand Raffles Medical Group has an analysts' consensus of -- which suggests that it could fall by --. Given that Mobile-health Network Solutions has higher upside potential than Raffles Medical Group, analysts believe Mobile-health Network Solutions is more attractive than Raffles Medical Group.
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 RAFLFRaffles Medical Group0 0 0 -
Is MNDR or RAFLF More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Raffles Medical Group has a beta of 0.097, suggesting its less volatile than the S&P 500 by 90.255%.
-
Which is a Better Dividend Stock MNDR or RAFLF?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Raffles Medical Group offers a yield of 2.66% to investors and pays a quarterly dividend of $0.02 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. Raffles Medical Group pays out 78.41% of its earnings as a dividend. Raffles Medical Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MNDR or RAFLF?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than Raffles Medical Group quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than Raffles Medical Group's net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while Raffles Medical Group's PE ratio is 27.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.93x versus 2.41x for Raffles Medical Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.93x -- -- -- RAFLFRaffles Medical Group2.41x 27.83x -- --
-
Which has Higher Returns MNDR or WVE?
WAVE Life Sciences has a net margin of -- compared to Mobile-health Network Solutions's net margin of -167.19%. Mobile-health Network Solutions's return on equity of -1223.46% beat WAVE Life Sciences's return on equity of -437.99%.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M WVEWAVE Life Sciences-- -$0.47 $141.6M -
What do Analysts Say About MNDR or WVE?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 2018.64%. On the other hand WAVE Life Sciences has an analysts' consensus of $22.30 which suggests that it could grow by 65.06%. Given that Mobile-health Network Solutions has higher upside potential than WAVE Life Sciences, analysts believe Mobile-health Network Solutions is more attractive than WAVE Life Sciences.
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 WVEWAVE Life Sciences7 1 0 -
Is MNDR or WVE More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison WAVE Life Sciences has a beta of -1.070, suggesting its less volatile than the S&P 500 by 207.018%.
-
Which is a Better Dividend Stock MNDR or WVE?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. WAVE Life Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. WAVE Life Sciences pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or WVE?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than WAVE Life Sciences quarterly revenues of -$7.7M. Mobile-health Network Solutions's net income of -- is lower than WAVE Life Sciences's net income of -$61.8M. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while WAVE Life Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.93x versus 31.64x for WAVE Life Sciences. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.93x -- -- -- WVEWAVE Life Sciences31.64x -- -$7.7M -$61.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Booking Holdings Stock Split?
Booking Holdings, the travel and technology company that owns brands…
Why Buy Domino’s Pizza Stock?
When you think of growth stocks, you probably imagine technology…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 121x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
70
OKLO alert for Jan 6
Oklo [OKLO] is up 10.09% over the past day.
Sell
39
DOGZ alert for Jan 6
Dogness (International) [DOGZ] is up 3.39% over the past day.
Buy
66
DMRC alert for Jan 6
Digimarc [DMRC] is up 1.05% over the past day.
